Skip to search formSkip to main contentSkip to account menu

Combivir

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
2010
2010
Objective:To determine the impact of once-nightly versus twice-daily dosing and beliefs about highly active antiretroviral… 
Highly Cited
2006
Highly Cited
2006
To compare the lipid and metabolic effects, efficacy, and safety of twice‐daily regimens of Trizivir® (abacavir 300 mg/lamivudine… 
Highly Cited
2004
Highly Cited
2004
Objective: Although most uninfected infants born to women infected with HIV-1 show no clinical evidence of mitochondrial… 
Review
2003
Review
2003
We present a case of psychosis in an individual with known HIV infection whose symptoms developed approximately 1 month following… 
Highly Cited
2001
Highly Cited
2001
Background Non-nucleoside reverse transcriptase inhibitor-containing regimens may be a valid alternative to protease inhibitor… 
Review
2001
Review
2001
I-172 6 Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in… 
Review
2000
Review
2000
SummaryAbstractSaquinavir is a potent and highly selective HIV protease inhibitor. Initially formulated as a hard-gel capsule…